Ibnsina Pharma reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EGP 9,108.17 million compared to EGP 5,550.26 million a year ago. Net income was EGP 42.03 million compared to EGP 30.99 million a year ago. Basic earnings per share from continuing operations was EGP 0.03 compared to EGP 0.02 a year ago.
For the nine months, sales was EGP 23,805.21 million compared to EGP 15,811.41 million a year ago. Net income was EGP 174.04 million compared to EGP 119.6 million a year ago. Basic earnings per share from continuing operations was EGP 0.14 compared to EGP 0.1 a year ago.